It is known that DNA damage can activate antitumor immune responses in cancer through release of cytosolic DNA leading to Stimulator of Interferon Genes (STING) pathway activation, production of neo-antigens, and release of pro-inflammatory cytokines. The gene discussed is STING1; the disease is cancer.